Pain relief during labor and delivery is a fundamental component of maternal care. Obstetric anaesthesia bridges pharmacology and midwifery, ensuring that mothers remain comfortable or pain-free during procedures ranging from normal vaginal deliveries to emergency Caesarean sections. The physiological changes of pregnancy—such as increased airway sensitivity, weight gain, and altered drug distribution—make pain management uniquely challenging in obstetric patients. Midwives must understand the basic categories of pain relief to provide safe care and monitor mothers effectively before and after administration.
Local anaesthetics temporarily block nerve impulses in a specific, localized area of the body without causing loss of consciousness. In midwifery practice, agents like Lignocaine (Lidocaine) and Bupivacaine are frequently used for perineal infiltration prior to an episiotomy or its repair, as well as for providing regional blocks such as epidurals and spinals during labor.
General anaesthesia induces a reversible state of unconsciousness, amnesia, and analgesia, rendering the patient completely unresponsive to surgical procedures. While regional techniques are preferred for most Caesarean deliveries, general anaesthesia is sometimes required for category-one emergencies where there is no time for an epidural or spinal block. Agents may be administered intravenously, such as Propofol, or via inhalation, such as Sevoflurane. A major physiological risk during general anaesthesia in pregnant women is the rapid onset of maternal hypoxia due to decreased functional residual capacity.
Understanding how these drugs work helps midwives anticipate both therapeutic effects and potential complications. Local anaesthetics work by binding to voltage-gated sodium channels on nerve cell membranes, preventing the influx of sodium ions necessary for depolarization and action potential propagation. Without this electrical conduction, pain signals cannot reach the brain. General anaesthetics act on various central nervous system receptors, notably enhancing inhibitory pathways like GABA and suppressing excitatory neurotransmission, leading to widespread depression of central nervous system activity.
Drugs administered to a pregnant woman readily cross the placenta via simple diffusion, meaning both local and general anaesthetic agents can affect the fetus. Midwives must monitor fetal heart rate patterns closely following regional blocks to detect potential fetal distress caused by maternal hypotension. Furthermore, high spinal or epidural blocks can paralyze intercostal muscles or the diaphragm if they spread too high, leading to respiratory compromise. Comprehensive post-procedure monitoring and immediate availability of resuscitation equipment are standard responsibilities for the midwifery team.
Adverse drug reactions range from mild allergic responses to life-threatening systemic toxicity. Local anaesthetic systemic toxicity (LAST) occurs when local agents inadvertently enter the blood vessel system in high doses, affecting the central nervous system and cardiovascular system. Early signs include circumoral numbness, a metallic taste in the mouth, tinnitus, and agitation, which can escalate rapidly to seizures and cardiac arrest. Intravenous Lipid Emulsion (20%) therapy is the established emergency antidote for severe LAST. Midwives must remain vigilant, recognize early symptoms instantly, and initiate emergency protocols without delay.